(Stroke. 2000;31:366.)
© 2000 American Heart Association, Inc.
Original Contributions |
Early [11C]Flumazenil/H2O Positron Emission Tomography Predicts Irreversible Ischemic Cortical Damage in Stroke Patients Receiving Acute Thrombolytic Therapy
From the Max-Planck Institut für neurologische Forschung and Neurologische Universitätsklinik, Cologne, Germany.
Correspondence to W.-D. Heiss, MD, Max-Planck Institut für neurologische Forschung, Gleueler Str. 50, D-50931 Köln, Germany.
Background and Purpose—Central benzodiazepine receptor ligands, such as [11C]flumazenil (FMZ), are markers of neuronal integrity and therefore might be useful in the differentiation of functionally and morphologically damaged tissue early in ischemic stroke. We sought to assess the value of a benzodiazepine receptor ligand for the early identification of irreversible ischemic damage to cortical areas that cannot benefit from reperfusion.
Methods—Eleven patients (7 male, 4 female, aged 52 to 75 years) with acute, hemispheric ischemic stroke were treated with alteplase (recombinant tissue plasminogen activator; 0.9 mg/kg according to National Institute of Neurological Disorders and Stroke protocol) within 3 hours of onset of symptoms. At the beginning of thrombolysis, cortical cerebral blood flow ([15O]H2O) and FMZ binding were assessed by positron emission tomography (PET). Those early PET findings were related to the change in neurological deficit (National Institutes of Health Stroke Scale) and to the extent of cortical damage on MRI or CT 3 weeks after the stroke.
Results—Hypoperfusion was observed in all cases, and in 8 patients the values were below critical thresholds estimated at 12 mL/100 g per minute, comprising 1 to 174 cm3 of cortical tissue. Substantial reperfusion was seen in most of these regions 24 hours after thrombolysis. In 4 cases, distinct areas of decreased FMZ binding were detected. Those patients suffered permanent lesions in cortical areas corresponding to their FMZ defects (112 versus 146, 3 versus 3, 2 versus 1, and 128 versus 136 cm3). In the other patients no morphological defects were detected on MRI or CT, although blood flow was critically decreased in areas ranging in size up to 78 cm3 before thrombolysis.
Conclusions—These findings suggest that imaging of benzodiazepine receptors by FMZ PET distinguishes between irreversibly damaged and viable penumbra tissue early after acute stroke.
Key Words: flumazenil • ligands • penumbra • stroke, acute • stroke, ischemic • thrombolytic therapy • tomography, emission computed
This article has been cited by other articles:
 |
|
 |
|
  A. S. Cunningham, R. Salvador, J. P. Coles, D. A. Chatfield, P. G. Bradley, A. J. Johnston, L. A. Steiner, T. D. Fryer, F. I. Aigbirhio, P. Smielewski, et al. Physiological thresholds for irreversible tissue damage in contusional regions following traumatic brain injury Brain, August 1, 2005; 128(8): 1931 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bouvard, N. Costes, F. Bonnefoi, F. Lavenne, F. Mauguiere, J. Delforge, and P. Ryvlin Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study Brain, June 1, 2005; 128(6): 1330 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nariai, Y. Shimada, K. Ishiwata, T. Nagaoka, J. Shimada, T. Kuroiwa, K.-I. Ono, K. Ohno, K. Hirakawa, and M. Senda PET Imaging of Adenosine A1 Receptors with 11C-MPDX as an Indicator of Severe Cerebral Ischemic Insult J. Nucl. Med., November 1, 2003; 44(11): 1839 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Koennecke Editorial Comment--Challenging the Concept of a Dynamic Penumbra in Acute Ischemic Stroke Stroke, October 1, 2003; 34(10): 2434 - 2435. [Full Text] [PDF]
|
|
|
|
|
|
C. Dohmen, B. Bosche, R. Graf, F. Staub, L. Kracht, J. Sobesky, M. Neveling, G. Brinker, and W.-D. Heiss Prediction of Malignant Course in MCA Infarction by PET and Microdialysis Stroke, September 1, 2003; 34(9): 2152 - 2158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kuge, K. Hikosaka, K.-i. Seki, K. Ohkura, K.-i. Nishijima, T. Kaji, S. Ueno, E. Tsukamoto, and N. Tamaki Characteristic Brain Distribution of 1-14C-Octanoate in a Rat Model of Focal Cerebral Ischemia in Comparison with Those of 123I-IMP and 123I-Iomazenil J. Nucl. Med., July 1, 2003; 44(7): 1168 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Eastwood, M. H. Lev, and J. M. Provenzale Perfusion CT with Iodinated Contrast Material Am. J. Roentgenol., January 1, 2003; 180(1): 3 - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takasawa, K. Kitagawa, T. Ohtsuki, N. Oku, K. Hashikawa, S. Sakoda, M. Hori, and M. Matsumoto Prominent Matched Hypoperfusion in an Intact Cerebellum after a Solitary Middle Cerebellar Peduncle Infarct AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1356 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Kent, V. M. Soukup, and R. H. Fabian Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse Stroke, October 1, 2001; 32(10): 2318 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Boysen and H. Christensen Early Stroke: A Dynamic Process Stroke, October 1, 2001; 32(10): 2423 - 2425. [Full Text] [PDF]
|
|
|
|
|
|
W.-D. Heiss, L. W. Kracht, A. Thiel, M. Grond, and G. Pawlik Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia Brain, January 1, 2001; 124(1): 20 - 29. [Abstract] [Full Text] [PDF]
|
|